Evaluation of [ 125I]7α-O-iodoallyl diprenophine as a new potential spect opioid receptor imaging agent

A new iodinated diprenorphine analog, [ 125I]7α-O-iodoallyl diprenorphine ([ 125I]7α-O-IA-DPN), was prepared by iododestannylation and characterized. As an opioid antagonist, this agent showed very high affinity (K i = 0.4 ± 0.2 nM) and 63% of specific binding by in vitro and in vivo binding studies...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nuclear medicine and biology 1997-08, Vol.24 (6), p.553-558
Hauptverfasser: Wang, R.F., Tafani, J.A.M., Francés, B., Bergon, M., Coulais, Y., Zajac, J.M., Guiraud, R.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A new iodinated diprenorphine analog, [ 125I]7α-O-iodoallyl diprenorphine ([ 125I]7α-O-IA-DPN), was prepared by iododestannylation and characterized. As an opioid antagonist, this agent showed very high affinity (K i = 0.4 ± 0.2 nM) and 63% of specific binding by in vitro and in vivo binding studies. Inhibition curves indicated that this tracer labeled with the same affinities to three opioid receptors (μ = δ = κ). The findings demonstrate that this proposed compound appears to be a potential radioprobe for future study of opioid receptors by in vivo SPECT.
ISSN:0969-8051
1872-9614
DOI:10.1016/S0969-8051(97)00068-1